Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients

Introduction: Parkinson's disease is the second most common neurodegenerative disease. Lifestyle, environmental effects and several genetic factors have been proposed to contribute to its development. Though the majority of PD cases do not have a family history of disease, genetic alterations a...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Boros Fanni Annamária
Török Rita
Sümegi Evelin
Pesei Zsófia Gabriella
Klivényi Péter
Vécsei László
Dokumentumtípus: Cikk
Megjelent: 2019
Sorozat:NEUROSCIENCE LETTERS 706
doi:10.1016/j.neulet.2019.05.014

mtmt:30756110
Online Access:http://publicatio.bibl.u-szeged.hu/17355
LEADER 03587nab a2200265 i 4500
001 publ17355
005 20191108153225.0
008 191108s2019 hu o 0|| zxx d
022 |a 0304-3940 
024 7 |a 10.1016/j.neulet.2019.05.014  |2 doi 
024 7 |a 30756110  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Boros Fanni Annamária 
245 1 0 |a Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients  |h [elektronikus dokumentum] /  |c  Boros Fanni Annamária 
260 |c 2019 
300 |a 140-145 
490 0 |a NEUROSCIENCE LETTERS  |v 706 
520 3 |a Introduction: Parkinson's disease is the second most common neurodegenerative disease. Lifestyle, environmental effects and several genetic factors have been proposed to contribute to its development. Though the majority of PD cases do not have a family history of disease, genetic alterations are proposed to be present in 60 percent of the more common sporadic cases. Objective: The aim of this study is to evaluate the frequency of PD related specific risk variants of LRRK2, MAPT, SNCA and PARK10 genes in the Hungarian population. Out of the ten investigated polymorphisms three are proposed to have protective effect and seven are putative risk factors. Methods: For genotyping, TaqMan allelic discrimination and restriction fragment length polymorphism method was used. LRRK2 mutations were investigated among 124 sporadic PD patients and 128 healthy controls. MAPT and SNCA variant frequencies were evaluated in a group of 123 patients and 122 controls, while PARK10 variant was studied in groups of 121 patients and 113 controls. Results: No significant difference could be detected in the frequencies of the investigated MAPT and PARK10 variants between the studied Hungarian PD cases and controls. The minor allele of the risk factor S1647T LRRK2 variant was found to be more frequent among healthy male individuals compared to patients. Moreover, in the frequency of one of the investigated SNCA variant a significant intergroup difference was detected. The minor allele (A) of rs356186 is proposed to be protective against developing the disease. In accord with data obtained in other populations, the AA genotype was significantly more frequent among Hungarian healthy controls compared to patients. Similarly, a significant difference in genotype distribution was also found in comparison of patients with late onset disease to healthy controls, which was due to the higher frequency of AG genotype among patients. Conclusion: The frequencies of different gene variants show great differences in populations. Assessment of the frequency of variants of PD related genes variants is important in order to uncover the pathomechanisms underlying the disease, and to identify potential therapeutic targets. This is the first comprehensive study focusing on these genetic variants in the population of East-Central European region. Our results extend the knowledge on the world wide occurrence of these polymorphisms by demonstrating the occurrence of specific alleles and absence of others in Hungarian PD patients. © 2019 Elsevier B.V. 
700 0 1 |a Török Rita  |e aut 
700 0 1 |a Sümegi Evelin  |e aut 
700 0 1 |a Pesei Zsófia Gabriella  |e aut 
700 0 1 |a Klivényi Péter  |e aut 
700 0 1 |a Vécsei László  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/17355/1/Veglegesites_AssessmentofriskfactorvariantsofLRRK2MAPTSNCAandTCEANC2genesinHungariansporadicParkinsonsdiseasepatients.pdf  |z Dokumentum-elérés